</Agent System Instructions>
<Blinded Review: TIME_ANON_0079>
**Composite Score:** 8.5 / 10.0 (Rigor: 2.9/3.5 | Claims: 2.1/2.5 | Biology: 1.8/2.0 | Reproducibility: 1.7/2.0)
**Bias Category:** None (Methodologically Sound)
**Verdict:** Minor Revision
**Study Modality:** Wet-Lab Primary Experimental
**Technology Maturity:** Mid-Stage High-Throughput
**Epistemic Stage:** Translational/Preclinical/Biomarker

---

### 1. Executive Summary
This experimental study develops and validates a combinatorial RNA interference (RNAi) strategy against HIV-1 by engineering the human `mir-17-92` (`mir-17-19b`) polycistronic pri-miRNA cluster under an RNA polymerase II (CMV) promoter to simultaneously express four distinct antiviral siRNAs targeting conserved regions of the HIV-1 LAI genome (`pol47`, `gag5`, `r/t5`, and `ldr9`). The authors systematically optimize guide-strand positioning (5' vs. 3' alignment within the wild-type mature miRNA duplex) and length (19 nt vs. 22–24 nt), quantify mature guide-strand processing via locked nucleic acid (LNA) Northern blotting, demonstrate that multimerizing hairpins within a single polycistronic transcript markedly increases Drosha/Dicer processing and target knockdown of individual hairpins, and show potent suppression of spreading HIV-1 replication in stably transduced SupT1 T cells (`ACDE` polycistron) without cellular toxicity over 36 days.

### 2. Methodological & Statistical Audit
- **Systematic Hairpin Design & Dual-Reporter Normalization:** For every single and multiplex construct (`A^{pol47}`, `B^{pol1}`, `C^{gag5}`, `D^{r/t5}`, `E^{ldr9}`), passenger strands were adjusted to preserve the bulges, mismatches, and Mfold-predicted secondary structure of the native `mir-17-19b` pri-miRNAs, including $\ge 40\text{ nt}$ single-stranded flanks required for Drosha–DGCR8 recognition. All firefly luciferase target reporter and HIV-1 pLAI CA-p24 ELISA co-transfections in 293T cells included 1 ng `pRL` (Renilla luciferase) for internal normalization of transfection efficiency and viability, pBluescript carrier DNA to equalize total DNA input, and matched positive (Pol III U6-driven `shRNA`s) and negative (`pBS`, wild-type `A^{wt}-E^{wt}`, and non-matching miRNAs) controls across $n=3$ to $4$ independent experiments (Figs. 3 and 5).
- **Mechanistic Dissection via Quantitative LNA Northern Blotting:**
  - Titrating `sh^{r/t5}` (39–2,500 ng) against `D^{r/t5}` (2,500 ng) on LNA Northern blots (Fig. 4) revealed that Pol II-driven `D^{r/t5}` produces 15–30-fold less mature 19-nt guide RNA than Pol III-driven `sh^{r/t5}`, yet achieves nearly equivalent knockdown of both `Luc-D^{r/t5}` and HIV-1 LAI production—demonstrating superior per-molecule intrinsic potency of endogenous pri-miRNA–routed effectors.
  - Furthermore, Northern blotting of the polycistronic series (`AB`, `AC`, `AD`, `ACC`, `ACD`, `ACCD`, `ACDE`, Fig. 6) directly explained the functional reporter data: chaining `A^{pol47}`, `C^{gag5}`, and `E^{ldr9}` into multi-hairpin transcripts strongly increased mature siRNA accumulation, whereas `B^{pol1}` accumulated only as an unprocessed ~60-nt pre-miRNA precursor without impairing processing of adjacent hairpins in `AB`.
- **Minor Limitations:**
  - **Absence of Long-Term Viral Escape Challenge:** While preventing HIV-1 mutational escape is the primary rationale for multiplexing four siRNAs, the viral challenge in FACS-sorted `ACDE`-transduced SupT1 cells was monitored for only 7 days (Fig. 7). Extended serial passage or high-MOI challenge to directly prove an elevated genetic barrier to escape relative to single-miRNA cell lines (`A^{pol47}`, `D^{r/t5}`, `E^{ldr9}`) is not included.
  - **Table 1 Omission in Manuscript Text:** Table 1 ("Structure and properties of the anti-HIV miRNAs", line 72) is empty in the formatted document, although its contents are described in the text and referenced in Supplementary Table 2.

### 3. Biological / Experimental Grounding & Claim Proportionality
- **Claim 1:** *"An antiviral miRNA construct can have a greater intrinsic inhibitory activity than a conventional short hairpin (shRNA) construct."* — `[Well Supported]`
  - Directly supported by comparing functional inhibition (Fig. 3) against phosphorimager-quantified LNA Northern blot titration showing 15–30-fold lower steady-state guide-strand levels from `D^{r/t5}` than `sh^{r/t5}` (Fig. 4).
- **Claim 2:** *"When combined in a polycistron setting, the silencing activity of an individual miRNA is strongly boosted."* — `[Well Supported]`
  - Demonstrated both by fusing `A^{pol47}` to wild-type `B^{wt}` or `A^{wt}-E^{wt}` hairpins (Fig. 5A) and across combinatorial antiviral polycistrons (`AC`, `AD`, `ACD`, `ACDE`) in reporter assays (Fig. 5B), HIV-1 pLAI production (Fig. 5C), and Northern blots (Fig. 6).
- **Claim 3:** *"HIV-1 replication can be efficiently inhibited by simultaneous expression of four antiviral siRNAs from the polycistronic miRNA transcript without cellular toxicity."* — `[Well Supported]`
  - Supported by the 36-day longitudinal FACS competition assay in unsorted transduced SupT1 cultures (Table 2, showing stable % $\text{GFP}^+$ fractions) and complete suppression of spreading HIV-1 LAI infection over 7 days in sorted `ACDE` SupT1 cells (Fig. 7).

### 4. Reproducibility & Data Completeness
- **Sequence & Probe Completeness:** Genomic template accession (`NT_009952.14`), HIV-1 LAI clone accession (`AF33819.3`), exact sequences and LNA modification positions of all five Northern blot probes (lines 51), lentiviral packaging plasmids (`pSYNGP`, `RSV-rev`, `pVSVg`), transduction MOI (`0.15`), and cloning/fusion-PCR protocols are thoroughly documented, with full oligonucleotide lists in Supplementary Table 1. Only the missing body of Table 1 in the main text requires restoration.
</Blinded Review: TIME_ANON_0079>
